Cardiac Critical Care
RCT | Combining loop with thiazide diuretics for decompensated heart failure.
1 Dec, 2022 | 14:02h | UTC
Commentary on Twitter
Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial https://t.co/wGfKpo03H6 @escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes pic.twitter.com/VfnQnp2AKa
— European Society of Cardiology Journals (@ESC_Journals) November 30, 2022
Review | Thrombolysis in cardiac arrest.
29 Nov, 2022 | 14:08h | UTCThrombolysis in Cardiac Arrest – emDocs
2ry analysis of a RCT | Decongestion with acetazolamide in acute heart failure across the spectrum of left ventricular EF.
25 Nov, 2022 | 12:45h | UTCOriginal Study: RCT | Acetazolamide resulted in faster decongestion in patients with acute decompensated heart failure with volume overload.
Commentary on Twitter
#OriginalResearch simpub #AHA2022 #CIRCAHA22: Acetazolamide added to loop diuretics ⬆️ likelihood of successful decongestion similarily in patients with HFrEF, HFmrEF and HFpEF. Data from the #ADVOR trial. @PieterMartensMD @WilfriedMullens #AHAJournals https://t.co/MkISN2H1vA pic.twitter.com/qFjCKdRaF6
— Circulation (@CircAHA) November 6, 2022
SR | Prothrombin complex concentrate in cardiac surgery for the treatment of coagulopathic bleeding.
24 Nov, 2022 | 13:24h | UTC
RCT | Impact of empagliflozin on decongestion in acute heart failure.
23 Nov, 2022 | 14:04h | UTCCommentary: Empagliflozin in Patients Hospitalized for Acute Heart Failure – EMPULSE – American College of Cardiology
Commentary on Twitter
What's the impact of empagliflozin on decongestion in acute heart failure? New insights from the EMPULSE trial in EHJ!https://t.co/O1MZTFPWCc#SGLT2 #decongestion #heartfailure #empagliflozin #cardiotwitter @escardio @ESC_Journals pic.twitter.com/QLJYNgl1Zo
— EHJ Editor-in-Chief (@ehj_ed) October 19, 2022
Under a https://creativecommons.org/licenses/by-nc/4.0/ license
M-A | Lower vs. higher exposure to vasopressor therapy in vasodilatory hypotension.
21 Nov, 2022 | 14:16h | UTC
Review | POCUS for aortic dissection in the clinical presentation of ischemic stroke.
17 Nov, 2022 | 12:08h | UTCPOCUS for aortic dissection in the clinical presentation of ischemic stroke – emDocs
RCT | Bivalirudin is superior to heparin in patients with ST-segment elevation myocardial infarction undergoing primary PCI.
15 Nov, 2022 | 13:00h | UTCCommentaries:
BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI – TCTMD
RCT | Early routine use of ECMO fails to improve outcomes in patients with cardiogenic shock.
11 Nov, 2022 | 14:01h | UTCCommentaries:
Early ECMO No Better Than Watch-and-Wait Approach in Cardiogenic Shock – TCTMD
Immediate Use of ECMO Did Not Improve Outcomes in Patients with Cardiogenic Shock – HCP Live
Commentary on Twitter
#OriginalResearch simpub #AHA2022: In this #RCT immediate implementation of VA-ECMO in patients with cardiogenic shock did not improve clinical outcomes compared with an early conservative strategy which allowed downstream use of… #CIRCAHA22 #AHAJournals https://t.co/03qVyC0Vgl pic.twitter.com/WRNDsAZfpD
— Circulation (@CircAHA) November 6, 2022
Review | Diagnosis of cardiac surgery-associated acute kidney injury.
10 Nov, 2022 | 13:27h | UTCRelated:
Clinical practice update for management of acute kidney injury associated with cardiac surgery.
RCT | Using an algorithm to stratify the risk of patients with acute heart failure may improve outcomes.
9 Nov, 2022 | 12:30h | UTCTrial of an Intervention to Improve Acute Heart Failure Outcomes – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: New Tool Assesses Risk in Acute HF Then Suggests Next Steps, Cutting Later Events – TCTMD
Commentary on Twitter
The use of a validated tool for risk assessment, combined with rapid follow-up, led to a lower risk of death or hospitalization for cardiovascular causes at 30 days among patients with acute heart failure. #AHA22 https://t.co/0cbvcHl3US pic.twitter.com/kpWbRGpOJX
— NEJM (@NEJM) November 5, 2022
RCT | New defibrillation strategies increased the rates of survival to hospital discharge in patients with refractory ventricular fibrillation.
8 Nov, 2022 | 12:27h | UTCDefibrillation Strategies for Refractory Ventricular Fibrillation – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: “Double shock” from two defibrillators could save more lives – Heart & Stroke
Commentary on Twitter
In a trial involving patients with refractory ventricular fibrillation, double sequential external defibrillation or vector-change defibrillation improved survival as compared with standard defibrillation. #AHA22 https://t.co/2l2t9iGnwq pic.twitter.com/SzVU93OsrX
— NEJM (@NEJM) November 6, 2022
RCT | Rapid up-titration of guideline-directed medical therapies for acute heart failure reduced readmissions and deaths.
8 Nov, 2022 | 12:24h | UTCSafety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial – The Lancet (free registration required)
News Release: Maximizing heart failure meds within 2 weeks reduced risk of hospital readmission, death – American Heart Association
Commentary: STRONG-HF: Rapid Uptitration of GDMT After Acute HF Pays Dividends – TCTMD
RCT | After an out-of-hospital cardiac arrest, fever prevention for 36 vs. 72 hours resulted in similar outcomes.
8 Nov, 2022 | 12:23h | UTCDuration of Device-Based Fever Prevention after Cardiac Arrest – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary on Twitter
In this trial involving patients after out-of-hospital cardiac arrest, fever prevention for 36 or 72 hours did not result in different percentages of patients dying or having severe disability or coma. #AHA22 https://t.co/Cx6x4RfqCE pic.twitter.com/vGSb0iVISN
— NEJM (@NEJM) November 6, 2022
Review | Targeted temperature management in postresuscitation care after incorporating results of the TTM2 Trial.
8 Nov, 2022 | 12:09h | UTCRelated:
Temperature Control After In-Hospital Cardiac Arrest: A Randomized Clinical Trial – Circulation
Hypothermic versus Normothermic Temperature Control after Cardiac Arrest – NEJM Evidence
ERC-ESICM guidelines on temperature control after cardiac arrest in adults – Intensive Care Medicine (if the link is paywalled, try this one)
Review | Optimal perfusion targets in cardiogenic shock.
31 Oct, 2022 | 13:45h | UTCOptimal Perfusion Targets in Cardiogenic Shock – JACC: Advances
Commentary on Twitter
#CardiogenicShock (CS) carries marked morbidity and mortality, w/ limited data to guide hemodynamic targets. Randomized #clinicaltrials in CS subsets are necessary to better elucidate optimal #perfusion targets. https://t.co/XpmXmlMdww#JACCAdvances #resuscitation #CardioTwitter pic.twitter.com/VWDEYkQ3nm
— JACC Journals (@JACCJournals) July 4, 2022
Evolving presentation of cardiogenic shock: a review of the medical literature and current practices.
31 Oct, 2022 | 13:46h | UTC
Commentary on Twitter
#CardiogenicShock remains a leading cause of morbidity and mortality among patients with #CardiovascularDisease. In his review, authors sought to survey the medical literature and provide an update on current practice. Read this in full here: https://t.co/lA0Hj9PWaM pic.twitter.com/Vz63n5pWfL
— Cardiology and Therapy (@Cardio_Therapy) August 8, 2022
Study commentary | From the management of altitude sickness to congestion in acute HF: a new season for acetazolamide?
27 Oct, 2022 | 12:27h | UTCFrom the management of altitude sickness to treatment of congestion in acute heart failure: a new season for acetazolamide? – European Heart Journal (free for a limited period)
Original study: RCT | Acetazolamide resulted in faster decongestion in patients with acute decompensated heart failure with volume overload.
New horizons in Type 2 myocardial infarction: pathogenesis, assessment and management of an emerging geriatric disease.
26 Oct, 2022 | 14:27h | UTC
Diaphragmatic function in cardiovascular disease: JACC review topic of the week.
25 Oct, 2022 | 13:22h | UTC
Post-trial follow-up | IV calcium does not improve long-term outcomes in patients with out-of-hospital cardiac arrest.
25 Oct, 2022 | 13:17h | UTCOriginal Study: RCT: Intravenous or intraosseous calcium does not improve the return of spontaneous circulation in adults with out-of-hospital cardiac arrest.
Commentary on Twitter
From the latest issue of @ResusJournal Effect of calcium vs. placebo on long-term outcomes in patients with out-of-hospital cardiac arrest https://t.co/fSCr9DebS7 pic.twitter.com/rRw28GwP5Q
— Emergency Medicine (@ELS_Emerg_Med) September 2, 2022
M-A | The optimal timing for non-culprit PCI in patients with multivessel coronary artery disease.
21 Oct, 2022 | 12:52h | UTC
Clinical practice update for management of acute kidney injury associated with cardiac surgery.
20 Oct, 2022 | 12:31h | UTCSociety of Cardiovascular Anesthesiologists Clinical Practice Update for Management of Acute Kidney Injury Associated With Cardiac Surgery – Anesthesia & Analgesia (free for a limited period)
Commentary on Twitter
The @scahq Clinical Practice Update for Management of Acute Kidney Injury Associated With Cardiac Surgery https://t.co/miFP5MkbnL @iars360
Potential renoprotective benefit:
❤️Goal-directed oxygen delivery on CPB
❤️KDIGO
❤️The use of vasopressin in vasoplegic shock pic.twitter.com/S9O2RtIhIr— Anesthesia&Analgesia (@IARS_Journals) October 13, 2022
Position Statement | Use of biomarkers for the management of heart failure and acute coronary syndrome.
17 Oct, 2022 | 12:34h | UTC
Guidelines for point-of-care ultrasound: part one (common heart and pulmonary applications).
17 Oct, 2022 | 12:32h | UTC